TABLE 2.
Groupa | Time (wpt) | No. of cattle | No. of nodules |
No. of worms per nodule site (no. of viable worms onlyb) in: |
Median motility score inc: |
|||
---|---|---|---|---|---|---|---|---|
Intact | Degeneratedd | Males | Females | Males | Females | |||
CON-1 | 0 | 6 | 6 | 0 | 1.7 | 1.3 | 2 | 2 |
4 | 6 | 6 | 0 | 3.3 | 1.3 | 1 | 2 | |
12 | 5 | 5 | 0 | 0.8 | 1.2 | 1.5 | 2 | |
24 | 5 | 5 | 0 | 1.4 | 1.0 (0.8) | 2 | 1 | |
36 | 5 | 5 | 0 | 2.2 (2.0) | 1.0 (0.8) | 1 | 1 | |
55 | 5 | 5 | 0 | 0.8 | 1.0 (0.8) | 2 | 2 | |
PIR | 0 | 6 | 6 | 0 | 4 | 1.2 | 2 | 2 |
4 | 6 | 6 | 0 | 1.5 | 1.0 | 1 | 1.5 | |
12 | 5 | 5 | 0 | 0.8 | 1.0 | 2 | 1 | |
24 | 5 | 4 | 1 | 0.2 (1.0) | 1.2 | 2 | 1 | |
36 | 5 | 5 | 0 | 0.4 (0.0) | 1.0 (0.2) | 0 | 0 | |
55e | 5 | 2 | 3 | 0 | 0.4 (0.2) | —f | 1 | |
OXY3-1 | 0 | 6 | 6 | 0 | 1.5 | 1.0 | 2 | 2 |
4 | 6 | 6 | 0 | 1.5 | 1.0 | 1 | 2 | |
12 | 6 | 6 | 0 | 0.8 | 1.0 | 2 | 1.5 | |
24 | 6 | 5 | 1 | 1.3 | 0.8 (0.7) | 1 | 1 | |
36 | 6 | 6 | 0 | 1.0 (0.3) | 1.0 (0.2) | 0 | 0 | |
55 | 6 | 2 | 4 | 0.2 | 0.3 | 2 | 1 | |
OXY6 | 0 | 6 | 6 | 0 | 1.5 | 1.2 | 2 | 2 |
4 | 6 | 6 | 0 | 1.7 | 1.0 (0.8) | 2 | 1.5 | |
12 | 4 | 4 | 0 | 2.0 | 1.0 | 2 | 2 | |
24 | 4 | 4 | 0 | 3.0 (2.0) | 1.3 (1.0) | 1 | 1 | |
36 | 4 | 4 | 0 | 0.3 | 1.0 (0.5) | 1 | 0.5 | |
55e | 4 | 2 | 2 | 0 | 0.5 (0.3) | —f | 0.5 | |
CON-2 | 0 | 6 | 6 | 0 | 0.8 | 1.0 | 2 | 2 |
4 | 6 | 6 | 0 | 1.2 | 1.0 | 2 | 2 | |
12 | 6 | 6 | 0 | 1.5 | 1.0 | 2 | 2 | |
24 | 6 | 6 | 0 | 1.5 | 1.0 (0.3) | 2 | 0 | |
36 | 6 | 5 | 1 | 1.5 | 0.8 | 2 | 2 | |
52 | 5 | 5 | 0 | 1.8 | 1.0 | 2 | 2 | |
OXY3-2 | 0 | 6 | 6 | 0 | 1.7 | 1.0 | 2 | 2 |
4 | 6 | 6 | 0 | 0.3 | 1.2 (1.0) | 1.5 | 1 | |
12 | 6 | 6 | 0 | 0.3 | 1.0 | 1.5 | 1 | |
24 | 6 | 6 | 0 | 0.5 | 1.0 (0.7) | 2 | 1 | |
36 | 6 | 6 | 0 | 0.7 | 1.0 (0.8) | 2 | 1 | |
52e | 6 | 6 | 0 | 0.3 | 1.0 (0.5) | 1 | 0.5 | |
RIF3 | 0 | 6 | 6 | 0 | 1.2 | 1.0 (0.8) | 2 | 2 |
4 | 6 | 6 | 0 | 2.0 | 1.0 | 1 | 1 | |
12 | 6 | 6 | 0 | 1.3 | 1.0 | 2 | 2 | |
24 | 6 | 6 | 0 | 0.5 | 1.0 (0.8) | 2 | 1 | |
36 | 6 | 6 | 0 | 0.3 | 1.0 (0.5) | 2 | 0.5 | |
52 | 6 | 6 | 0 | 0.8 (0.5) | 1.0 (0.8) | 1 | 1 | |
COM | 0 | 6 | 6 | 0 | 0.8 | 1.0 | 2 | 1.5 |
4 | 6 | 6 | 0 | 1.3 | 1.0 | 2 | 2 | |
12 | 6 | 6 | 0 | 0.5 | 1.0 | 2 | 2 | |
24 | 6 | 6 | 0 | 1.3 | 1.0 (0.8) | 2 | 1 | |
36 | 6 | 5 | 1 | 1.0 | 0.8 | 1.5 | 2 | |
52 | 6 | 6 | 0 | 0.3 | 1.0 (0.7) | 1.5 | 2 |
CON-1, no treatment; PIR, oxytetracycline once monthly for 6 months; OXY3-1 and OXY3-2, oxytetracycline twice weekly for 3 weeks; OXY6, oxytetracycline twice weekly for 6 weeks; CON-2, DMSO solvent only; RIF3, rifampin twice weekly for 3 weeks; COM; rifampin and oxytetracycline twice weekly for 3 weeks.
Worms were considered viable where the motility score was ≥1. Note that O. ochengi nodules normally contain a single female worm and a variable number of males (0 to >10).
Motility was scored on a 3-point scale after incubation of worms for 30 min at 37°C, as follows: 0, no movement; 1, sluggish movement; and 2, highly active.
“Degenerated” refers to worm remnants only or fragmented nodules from skin biopsy specimens (in which fragmentation was too advanced to allow sexing and motility scoring).
The total number of viable worms recovered at the end of the experiment was significantly reduced compared with the number in control animals (P < 0.05).
Data were missing due to the absence of male worms in all nodules.